SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma
SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.
Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.
Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.
![](/api/deal-hero-image/105534/deal-hero-image.jpg)
![](/api/deal-party-images/105534/deal-parties.png)
Talk to the deal team
Related deals
Provital GmbH has been acquired by EMERAM Capital Partners
Dr. Thomas Brandner has sold a majority stake in Provital GmbH to private equity firm EMERAM Capital Partners. The transaction secures the future development and growth opportunities of the pet food company as EMERAM Capital Partners takes on ownership and acts as its strategic partner.
Learn moreVenus Wine & Spirit Merchants plc has been acquired by Booker Group Ltd., a subsidiary of Tesco plc
The shareholders of Venus Wine & Spirit Merchants plc have sold the company to Booker Group Ltd., a subsidiary of Tesco plc. The move allows the Tesco subsidiary to bolster its on-trade portfolio through the addition of Venus’ range of over 2,000 spirits, beers, wines and soft drinks.
Learn moreKees Smit Tuinmeubelen has been acquired by Craft Capital
Kees Smit Tuinmeubelen, a leading family-owned omnichannel retailer of garden furniture and related accessories, has agreed to sell a majority stake to Craft Capital, a Netherlands-based investment firm. The transaction is still subject to fulfillment of customary closing conditions.
Learn more